GSA Capital Partners’s CareDx CDNA Stock Holding History

GSA Capital Partners’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$725K	Buy	+25,440	New	+$554K	0.05%	737
2026 Q1	–	Sell	-23,689	Closed	-$446K	–	1765
2025 Q4	$446K	Sell	23,689 -6,981	-23%	-$117K	0.04%	897
2025 Q3	$446K	Buy	+30,670	New	+$437K	0.04%	928
2024 Q2	–	Sell	-17,529	Closed	-$186K	–	1659
2024 Q1	$186K	Sell	17,529 -763	-4%	-$7.63K	0.01%	1416
2023 Q4	$220K	Sell	18,292 -47,722	-72%	-$391K	0.02%	1276
2023 Q3	$462K	Buy	66,014 +20,732	+46%	+$192K	0.04%	842
2023 Q2	$385K	Sell	45,282 -130,779	-74%	-$1.09M	0.04%	898
2023 Q1	$1.61M	Buy	+176,061	New	+$2.25M	0.16%	122
2020 Q2	–	Sell	-11,584	Closed	-$253K	–	671
2020 Q1	$253K	Sell	11,584 -3,666	-24%	-$82.1K	0.06%	597
2019 Q4	$329K	Buy	15,250 +3,086	+25%	+$70.8K	0.04%	954
2019 Q3	$275K	Buy	+12,164	New	+$337K	0.04%	972

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GSA Capital Partners's CDNA Position: Q2 2026 in Review

GSA Capital Partners opened a new position in CareDx (CDNA) in Q2 2026: 25,440 shares worth $725K. The stake represents 0.05% of the portfolio and ranks #737 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in CDNA as recently as Q4 2025.

GSA Capital Partners first reported a position in CDNA in Q3 2019 and has held it in 11 quarters since. The position peaked at $1.61M in Q1 2023. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

GSA Capital Partners held 25,440 shares of CareDx worth $725K as of Q2 2026.
CareDx was a new GSA Capital Partners position in Q2 2026.
CareDx made up 0.05% of GSA Capital Partners's portfolio in Q2 2026, its #737 holding.
GSA Capital Partners first reported a position in CareDx in Q3 2019 and has held it in 11 quarters since.
GSA Capital Partners's CareDx position peaked at $1.61M in Q1 2023.
227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.